Skip to main content
Advertisement
Advertisement
BNGO
BNGO logo
Bionano Genomics, Inc. Common Stock
0.95
USD
Sponsored
+0.02
+2.50%
Nov 18, 15:56 UTC -5
Closed
exchange

Pre-Market

0.97

+0.02
+1.99%

Bionano Genomics, Inc. Common Stock (BNGO) Earnings

BNGO Earnings Reports

Positive Surprise Ratio

BNGO beat 13 of 33 last estimates.

39%

Next Report

Date of Next Report
Mar 22, 2027
Estimate for Q4 26 (Revenue/ EPS)
$9.36M
/
-$0.45
Implied change from Q3 26 (Revenue/ EPS)
+13.04%
/
-16.67%
Implied change from Q4 25 (Revenue/ EPS)
+17.66%
/
+1400.00%

Bionano Genomics, Inc. Common Stock earnings per share and revenue

On Nov 10, 2026, BNGO reported earnings of -0.54 USD per share (EPS) for Q3 26, missing the estimate of -0.49 USD, resulting in a -8.04% surprise. Revenue reached 8.28 million, compared to an expected 8.61 million, with a -3.90% difference. The market reacted with a -10.57% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.45 USD, with revenue projected to reach 9.36 million USD, implying an decrease of -16.67% EPS, and increase of 13.04% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Rein Therapeutics, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.10
Actual
-$0.06
Surprise
+41.18%
logo
Instil Bio, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.62
Surprise
-261.09%
logo
Estrella Immunopharma, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.17
Surprise
-108.33%
logo
AYTU BioPharma, Inc. Common Stock
Report Date
Nov 16, 2026 For Q1 27
Estimate
-$0.26
Actual
-$0.20
Surprise
+23.61%
logo
Jasper Therapeutics, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$3.02
Actual
-$13.97
Surprise
-361.93%
logo
Kyntra Bio, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$3.61
Actual
-$3.42
Surprise
+5.49%
logo
Lantern Pharma Inc. Common Stock
Report Date
Nov 17, 2026 For Q3 26
Estimate
-$0.35
Actual
-$0.81
Surprise
-126.89%
logo
Pulmatrix, Inc. Common Stock
Report Date
Nov 17, 2026 For Q3 26
Estimate
-
Actual
-$0.34
Surprise
-
logo
Senti Biosciences Holdings, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.30
Actual
-$0.37
Surprise
-22.96%
logo
MapLight Therapeutics, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$1.19
Actual
-$0.97
Surprise
+18.86%
FAQ
For Q3 2026, Bionano Genomics, Inc. Common Stock reported EPS of -$0.54, missing estimates by -8.04%, and revenue of $8.28M, -3.9% below expectations.
The stock price moved down -10.57%, changed from $1.23 before the earnings release to $1.10 the day after.
The next earning report is scheduled for Mar 22, 2027.
Based on -- analysts, Bionano Genomics, Inc. Common Stock is expected to report EPS of -$0.45 and revenue of $9.36M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement